961.22
961.22
Schedule V. Unless specifically excepted by state or federal law or regulation or more specifically included in another schedule, the following controlled substances are listed in schedule V:
961.22(2)
(2) Narcotic drugs containing nonnarcotic active medicinal ingredients. Any compound, mixture or preparation containing any of the following narcotic drugs or their salts, isomers or salts of isomers, in limited quantities as set forth below, calculated as the free anhydrous base or alkaloid, which also contains one or more nonnarcotic, active medicinal ingredients in sufficient proportion to confer upon the compound, mixture or preparation, valuable medicinal qualities other than those possessed by the narcotic drug alone:
961.22(2)(a)
(a) Not more than 200 milligrams of codeine per 100 milliliters or per 100 grams.
961.22(2)(b)
(b) Not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams.
961.22(2)(c)
(c) Not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams.
961.22(2)(d)
(d) Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit.
961.22(2)(e)
(e) Not more than 100 milligrams of opium per 100 milliliters or per 100 grams.
961.22(2)(f)
(f) Not more than 0.5 milligrams of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit.
961.22(2m)
(2m) Pseudoephedrine. Pseudoephedrine or any of its salts, isomers, or salts of isomers.
961.22(3)
(3) Other stimulants. Any material, compound, mixture or preparation which contains any quantity of any of the following substances having a stimulant effect on the central nervous system, including any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:
961.22(4)
(4) Ezogabine. Ezogabine or any of its salts, isomers, or salts of isomers.
961.22(5)
(5) Pregabalin. Pregabalin or any of its salts, isomers, or salts of isomers.
961.22 History
History: 1971 c. 219;
1981 c. 206; CSB 2.15;
1985 a. 135; CSB 2.17;
1995 a. 448 ss.
223 to
227,
481; Stats. 1995 s. 961.22; CSB 2.17 (1);
2005 a. 14,
262;
2013 a. 351.
961.23
961.23
Dispensing of schedule V substances. The dispensing of schedule V substances is subject to the following conditions:
961.23(1)
(1) They may be dispensed and sold only in good faith as a medicine and not for the purpose of evading this chapter.
961.23(2)
(2) They may be sold at retail only by a registered pharmacist or, if the substance is a pseudoephedrine product, by a person who is working under the direction of a registered pharmacist when sold in a retail establishment.
961.23(3)
(3) When sold in a retail establishment, they shall bear the name and address of the establishment on the immediate container of said preparation.
961.23(4)
(4) Any person purchasing such a substance shall, at the time of purchase, present to the seller that person's correct name, address, and, if the person is purchasing a pseudoephedrine product, an identification card containing the person's photograph. The seller shall record the name and address and the name and quantity of the product sold. The purchaser and either the seller or, if the substance is a pseudoephedrine product and is being sold by a person who is not a registered pharmacist, the pharmacist supervising the seller shall sign the record of this transaction. The giving of a false name or false address by the purchaser shall be prima facie evidence of a violation of
s. 961.43 (1) (a).
961.23(5)
(5) No person may purchase more than 227 grams of a product containing opium or more than 113 grams of a product containing any other schedule V substance within a 48-hour period without the authorization of a physician, dentist, or veterinarian. This subsection does not apply to a pseudoephedrine product unless it contains another schedule V substance.
961.23(6)
(6) No person other than a physician, dentist, veterinarian, or pharmacist may purchase more than 7.5 grams of pseudoephedrine contained in a pseudoephedrine product within a 30-day period without the authorization of a physician, dentist, or veterinarian.
961.23(7)
(7) No person other than a physician, dentist, veterinarian, or pharmacist may possess more than 227 grams of a product containing opium or more than 113 grams of a product containing any other schedule V substance at any time without the authorization of a physician, dentist, or veterinarian. This subsection does not apply to a pseudoephedrine product unless it contains another schedule V substance.
961.23(8)
(8) No person may sell a pseudoephedrine product to a person under 18 years of age, and no person under 18 years of age may purchase a pseudoephedrine product.
961.235
961.235
Records relating to sales of pseudoephedrine products. 961.235(1)(1) In this section, "records of pseudoephedrine sales" means records required under
s. 961.23 (4) with respect to the sale of a pseudoephedrine product.
961.235(2)
(2) Records of pseudoephedrine sales may be kept in either a paper or electronic format and shall be maintained by the pharmacy for at least 2 years. Except as provided in
sub. (3), only a pharmacist may have access to records of pseudoephedrine sales and information contained in those records.
961.235(3)
(3) A pharmacist shall make records required under
s. 961.23 (4) available to a law enforcement officer who requests them. Law enforcement officers may make those records available to other persons or redisclose information from those records to other persons only in connection with a criminal investigation or prosecution under this chapter.
961.235 History
History: 2005 a. 14,
262.
961.24
961.24
Publishing of updated schedules. The controlled substances board shall publish updated schedules annually. The failure of the controlled substances board to publish an updated schedule under this section is not a defense in any administrative or judicial proceeding under this chapter.
961.24 History
History: 1971 c. 219;
1993 a. 213;
1995 a. 448 s.
229; Stats. 1995 s. 961.24.
961.25
961.25
Controlled substance analog treated as a schedule I substance. A controlled substance analog, to the extent it is intended for human consumption, shall be treated, for the purposes of this chapter, as a substance included in schedule I, unless a different treatment is specifically provided. No later than 60 days after the commencement of a prosecution concerning a controlled substance analog, the district attorney shall provide the controlled substances board with information relevant to emergency scheduling under
s. 961.11 (4m). After a final determination by the controlled substances board that the controlled substance analog should not be scheduled, no prosecution relating to that substance as a controlled substance analog may be commenced or continued.
961.25 History
History: 1995 a. 448.
REGULATION OF MANUFACTURE, DISTRIBUTION AND DISPENSING OF CONTROLLED SUBSTANCES
Effective date note
NOTE: Subchapter III (title) is amended eff. 7-1-15 by
2013 Wis. Act 198 to read:
Effective date text
REGULATION OF MANUFACTURE, DISTRIBUTION, DISPENSING, AND POSSESSION OF CONTROLLED SUBSTANCES
961.31
961.31
Rules. The pharmacy examining board may promulgate rules relating to the manufacture, distribution and dispensing of controlled substances within this state.
961.31 History
History: 1971 c. 219;
1995 a. 448 s.
231; Stats. 1995 s. 961.31.
961.31 Cross-reference
Cross-reference: See also ch.
Phar 8, Wis. adm. code.
961.32
961.32
Possession authorization. 961.32(1)
(1) Persons registered under federal law to manufacture, distribute, dispense or conduct research with controlled substances may possess, manufacture, distribute, dispense or conduct research with those substances in this state to the extent authorized by their federal registration and in conformity with the other provisions of this chapter.
961.32(2)
(2) The following persons need not be registered under federal law to lawfully possess controlled substances in this state:
961.32(2)(a)
(a) An agent or employee of any registered manufacturer, distributor or dispenser of any controlled substance if the agent or employee is acting in the usual course of the agent's or employee's business or employment;
961.32(2)(b)
(b) A common or contract carrier or warehouse keeper, or an employee thereof, whose possession of any controlled substance is in the usual course of business or employment;
961.32(2)(c)
(c) An ultimate user or a person in possession of any controlled substance pursuant to a lawful order of a practitioner or in lawful possession of a schedule V substance.
961.32(2)(d)
(d) Any person exempted under federal law, or for whom federal registration requirements have been waived.
961.32(2)(e)
(e) A person actively engaged in the direct operation or implementation of a drug disposal program that is authorized under
s. 165.65 (2) or
(3) or is authorized under federal law, as defined in
s. 165.65 (1) (a).
961.32 History
History: 1971 c. 219,
336;
1983 a. 500 s.
43;
1993 a. 482;
1995 a. 448 s.
232; Stats. 1995 s. 961.32;
2013 a. 198.
961.32 Annotation
A doctor or dentist who dispenses drugs to a patient within the course of professional practice is not subject to criminal liability. State v. Townsend,
107 Wis. 2d 24,
318 N.W.2d 361 (1982).
961.335
961.335
Special use authorization. 961.335(1)
(1) Upon application the controlled substances board may issue a permit authorizing a person to manufacture, obtain, possess, use, administer or dispense a controlled substance for purposes of scientific research, instructional activities, chemical analysis or other special uses, without restriction because of enumeration. No person shall engage in any such activity without a permit issued under this section, except that an individual may be designated and authorized to receive the permit for a college or university department, research unit or similar administrative organizational unit and students, laboratory technicians, research specialists or chemical analysts under his or her supervision may be permitted possession and use of controlled substances for these purposes without obtaining an individual permit.
Effective date note
NOTE: Sub. (1) is affected eff. 7-1-15 by
2013 Wis. Act 198 to read:
Effective date text
(1) (a) Upon application the controlled substances board may issue a permit authorizing a person to manufacture, obtain, possess, use, administer, or dispense a controlled substance for purposes of scientific research, instructional activities, chemical analysis, or other special uses, without restriction because of enumeration.
Effective date text
(b) Except as provided in par. (c), no person may engage in any activity described under par. (a) without a permit issued under this section.
Effective date text
(c) 1. A person who is actively engaged in the direct operation or implementation of a drug disposal program that is authorized under s. 165.65 (2) or (3) or is authorized under federal law, as defined in s. 165.65 (1) (a), may, without a permit issued under this section, obtain or possess a controlled substance for the purposes of operating and implementing the drug disposal program.
Effective date text
2. A person who is permitted under federal law to dispose of a controlled substance may, without a permit issued under this section, possess the controlled substance for the purpose of disposing of the controlled substance.
Effective date text
3. An individual who is designated and authorized to receive a permit under this section for a college or university department, research unit, or similar administrative organizational unit, and students, laboratory technicians, research specialists, or chemical analysts under his or her supervision, may, without an additional permit issued under this section, possess and use a controlled substance, for the purposes authorized in the permit received for the department or unit.
961.335(2)
(2) A permit issued under this section shall be valid for one year from the date of issue.
961.335(3)
(3) The fee for a permit under this section shall be an amount determined by the controlled substances board but shall not exceed $25. No fee may be charged for permits issued to employees of state agencies or institutions.
961.335(4)
(4) Permits issued under this section shall be effective only for and shall specify:
961.335(4)(b)
(b) The nature of the project authorized by the permit.
961.335(4)(c)
(c) The controlled substances to be used in the project, by name if included in schedule I, and by name or schedule if included in any other schedule.
961.335(4)(d)
(d) Whether dispensing to human subjects is authorized.
961.335(5)
(5) A permit shall be effective only for the person, substances and project specified on its face and for additional projects which derive directly from the stated project. Upon application, a valid permit may be amended to add a further activity or to add further substances or schedules to the project permitted thereunder. The fee for such amendment shall be determined by the controlled substances board but shall not exceed $5.
961.335(6)
(6) Persons who possess a valid permit issued under this section are exempt from state prosecution for possession and distribution of controlled substances to the extent of the authorization.
961.335(7)
(7) The controlled substances board may authorize persons engaged in research on the use and effects of controlled substances to withhold the names and other identifying characteristics of individuals who are the subjects of research. Persons who obtain this authorization are not compelled in any civil, criminal, administrative, legislative or other proceeding to identify or to identify to the board the individuals who are the subjects of research for which the authorization was obtained.
961.335(8)
(8) The controlled substances board may promulgate rules relating to the granting of special use permits including, but not limited to, requirements for the keeping and disclosure of records other than those that may be withheld under
sub. (7), submissions of protocols, filing of applications and suspension or revocation of permits.
961.335 Cross-reference
Cross-reference: See also ch.
CSB 3, Wis. adm. code.
961.335(9)
(9) The controlled substances board may suspend or revoke a permit upon a finding that there is a violation of the rules of the board.
961.335 History
History: 1971 c. 219;
1975 c. 110,
199;
1977 c. 26;
1995 a. 448 s.
233; Stats. 1995 s. 961.335;
2013 a. 198.
961.337
961.337
Drug disposal programs. Nothing in this chapter, or rules promulgated under this chapter, prohibits any of the following:
961.337(1)
(1) The direct operation or implementation of a drug disposal program that is authorized under
s. 165.65 (2) or
(3) or is authorized under federal law, as defined in
s. 165.65 (1) (a).
961.337(2)
(2) The transfer by the ultimate user, or by another person that lawfully possesses the controlled substance or controlled substance analog, of a controlled substance or controlled substance analog to a drug disposal program that has been authorized under
s. 165.65 (2) or
(3) or is authorized under federal law, as defined in
s. 165.65 (1) (a), and that accepts the controlled substance or controlled substance analog.
961.337 History
History: 2013 a. 198.
961.34
961.34
Controlled substances therapeutic research. 961.34(1)(1) Upon the request of any practitioner, the controlled substances board shall aid the practitioner in applying for and processing an investigational drug permit for marijuana under
21 USC 355 (i). If the federal food and drug administration issues an investigational drug permit, the controlled substances board shall approve which pharmacies can distribute the marijuana to patients upon written prescription. Only pharmacies located within hospitals are eligible to receive the marijuana for distribution. The controlled substances board shall also approve which practitioners can write prescriptions for the marijuana.
961.34(2)(a)(a) Upon the request of any physician, the controlled substances board shall aid the physician in applying for and processing an investigational drug permit under
21 USC 355 (i) for cannabidiol as treatment for a seizure disorder. If the federal food and drug administration issues an investigational drug permit, the controlled substances board shall approve which pharmacies and physicians may dispense cannabidiol to patients.
961.34(2)(b)
(b) If cannabidiol is removed from the list of controlled substances, or if cannabidiol is determined not to be a controlled substance, under schedule I of
21 USC 812 (c), the controlled substances board shall approve which pharmacies and physicians may dispense cannabidiol to patients as treatment for a seizure disorder.
961.34 History
History: 1981 c. 193;
1983 a. 189 s.
329 (18);
1985 a. 146 s.
8;
1995 a. 448 ss.
16 to
19; Stats. 1995 s. 961.34;
2013 a. 267.
961.34 Annotation
Reefer Madness: Lighting Up in the Dairyland. Bailey. Wis. Law. Nov. 2014.
961.36
961.36
Controlled substances board duties relating to diversion control and prevention, compliance with controlled substances law and advice and assistance. 961.36(1)(1) The controlled substances board shall regularly prepare and make available to state regulatory, licensing and law enforcement agencies descriptive and analytic reports on the potential for diversion and actual patterns and trends of distribution, diversion and abuse within the state of certain controlled substances the board selects that are listed in
s. 961.16,
961.18,
961.20 or
961.22.
961.36(1m)
(1m) At the request of the department of safety and professional services or a board, examining board or affiliated credentialing board in the department of safety and professional services, the controlled substances board shall provide advice and assistance in matters related to the controlled substances law to the department or to the board, examining board or affiliated credentialing board in the department making the request for advice or assistance.
961.36(2)
(2) The controlled substances board shall enter into written agreements with local, state and federal agencies to improve the identification of sources of diversion and to improve enforcement of and compliance with this chapter and other laws and regulations pertaining to unlawful conduct involving controlled substances. An agreement must specify the roles and responsibilities of each agency that has information or authority to identify, prevent or control drug diversion and drug abuse. The board shall convene periodic meetings to coordinate a state diversion prevention and control program. The board shall assist and promote cooperation and exchange of information among agencies and with other states and the federal government.
